Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $2.68 Million Holdings in Envista Holdings Co. (NYSE:NVST)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Envista Holdings Co. (NYSE:NVST) by 7.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 79,132 shares of the company’s stock after buying an additional 5,626 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Envista were worth $2,678,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Alliancebernstein L.P. raised its position in shares of Envista by 50.5% in the 4th quarter. Alliancebernstein L.P. now owns 4,209,467 shares of the company’s stock valued at $141,733,000 after buying an additional 1,412,915 shares in the last quarter. Norges Bank bought a new stake in Envista during the fourth quarter worth $32,880,000. Loomis Sayles & Co. L P acquired a new stake in shares of Envista in the 1st quarter valued at $30,335,000. Macquarie Group Ltd. increased its stake in shares of Envista by 14.4% in the 1st quarter. Macquarie Group Ltd. now owns 4,157,392 shares of the company’s stock valued at $169,954,000 after purchasing an additional 524,622 shares during the last quarter. Finally, Point72 Asset Management L.P. raised its holdings in shares of Envista by 93.8% during the 4th quarter. Point72 Asset Management L.P. now owns 963,508 shares of the company’s stock worth $32,441,000 after buying an additional 466,461 shares in the last quarter.

Insider Transactions at Envista

In other news, CEO Amir Aghdaei bought 10,000 shares of the company’s stock in a transaction that occurred on Monday, November 6th. The shares were acquired at an average price of $21.53 per share, for a total transaction of $215,300.00. Following the completion of the acquisition, the chief executive officer now directly owns 295,362 shares in the company, valued at $6,359,143.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Envista news, CEO Amir Aghdaei bought 10,000 shares of the stock in a transaction on Monday, November 6th. The stock was acquired at an average cost of $21.53 per share, for a total transaction of $215,300.00. Following the completion of the acquisition, the chief executive officer now owns 295,362 shares in the company, valued at approximately $6,359,143.86. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Stephen Keller purchased 2,000 shares of the business’s stock in a transaction on Monday, November 6th. The shares were acquired at an average price of $21.53 per share, for a total transaction of $43,060.00. Following the completion of the acquisition, the insider now directly owns 13,070 shares in the company, valued at approximately $281,397.10. The disclosure for this purchase can be found here. Insiders bought a total of 19,185 shares of company stock worth $417,125 over the last three months. 1.20% of the stock is owned by company insiders.

Envista Trading Up 1.3 %

NYSE NVST opened at $23.76 on Tuesday. The firm has a market capitalization of $4.07 billion, a PE ratio of 22.00, a price-to-earnings-growth ratio of 3.32 and a beta of 1.47. The business’s 50-day moving average price is $25.24 and its two-hundred day moving average price is $30.59. The company has a current ratio of 2.20, a quick ratio of 1.82 and a debt-to-equity ratio of 0.32. Envista Holdings Co. has a 12 month low of $20.00 and a 12 month high of $43.29.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, November 1st. The company reported $0.43 EPS for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.03). Envista had a return on equity of 7.29% and a net margin of 7.39%. The company had revenue of $631.30 million during the quarter, compared to analyst estimates of $647.94 million. During the same period in the prior year, the firm earned $0.47 earnings per share. Envista’s revenue was up .0% compared to the same quarter last year. On average, analysts expect that Envista Holdings Co. will post 1.62 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on NVST. Evercore ISI reduced their price objective on Envista from $40.00 to $30.00 in a research note on Wednesday, October 11th. Stifel Nicolaus decreased their price target on shares of Envista from $45.00 to $36.00 and set a “buy” rating on the stock in a report on Wednesday, November 1st. Morgan Stanley dropped their price objective on shares of Envista from $42.00 to $38.00 and set an “overweight” rating for the company in a research note on Thursday, November 2nd. JPMorgan Chase & Co. decreased their target price on shares of Envista from $42.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday, November 2nd. Finally, The Goldman Sachs Group dropped their price target on Envista from $41.00 to $28.00 and set a “buy” rating for the company in a research note on Friday, November 3rd. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $34.63.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.